- Weitere Titel
-
Mutierte Isozitrat-Dehydrogenase 1 als Zielstruktur für einen Krebsimmuntherapieansatz
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2014
- Klassifikation
-
Naturwissenschaften
- Schlagwort
-
Cancer--Immunotherapy
Vaccination
T cells
Immunotherapy
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2014
- Urheber
- Beteiligte Personen und Organisationen
-
Platten, Michael
- DOI
-
10.11588/heidok.00016805
- URN
-
urn:nbn:de:bsz:16-heidok-168052
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schumacher, Theresa
- Platten, Michael
- Universitätsbibliothek Heidelberg
Entstanden
- 2014
Ähnliche Objekte (12)
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Exploring mutant p53 targeting strategies for cancer therapy
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Targeting mutant KRAS in pancreatic cancer: futile or promising?
Immunotherapy of Colorectal Cancer
Cancer immunology and immunotherapy
Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Lymphocytes in immunotherapy of cancer
Recent advances in cancer immunotherapy
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Exploring mutant p53 targeting strategies for cancer therapy
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Targeting mutant KRAS in pancreatic cancer: futile or promising?
Immunotherapy of Colorectal Cancer
Cancer immunology and immunotherapy
Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Lymphocytes in immunotherapy of cancer
Recent advances in cancer immunotherapy
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Exploring mutant p53 targeting strategies for cancer therapy
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Targeting mutant KRAS in pancreatic cancer: futile or promising?
Immunotherapy of Colorectal Cancer
Cancer immunology and immunotherapy
Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Lymphocytes in immunotherapy of cancer
Recent advances in cancer immunotherapy